Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 1375

    1.

    Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

    Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechinski J, Li T, Ge Z, Becker JC, Westhovens R.

    Ann Intern Med. 2006 Jun 20;144(12):865-76.PMID: 16785475 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.

    Schiff M, Keiserman M, Codding C, Songcharoen S, Berman A, Nayiager S, Saldate C, Li T, Aranda R, Becker JC, Lin C, Cornet PL, Dougados M.

    Ann Rheum Dis. 2008 Aug;67(8):1096-103. Epub 2007 Nov 29.PMID: 18055472 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy.

    Genovese MC, Schiff M, Luggen M, Becker JC, Aranda R, Teng J, Li T, Schmidely N, Le Bars M, Dougados M.

    Ann Rheum Dis. 2008 Apr;67(4):547-54. Epub 2007 Oct 5.PMID: 17921185 [PubMed - indexed for MEDLINE]Related articles

    4.

    Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial.

    Kremer JM, Dougados M, Emery P, Durez P, Sibilia J, Shergy W, Steinfeld S, Tindall E, Becker JC, Li T, Nuamah IF, Aranda R, Moreland LW.

    Arthritis Rheum. 2005 Aug;52(8):2263-71. Erratum in: Arthritis Rheum. 2005 Oct;52(10):3321. PMID: 16052582 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition.

    Genovese MC, Becker JC, Schiff M, Luggen M, Sherrer Y, Kremer J, Birbara C, Box J, Natarajan K, Nuamah I, Li T, Aranda R, Hagerty DT, Dougados M.

    N Engl J Med. 2005 Sep 15;353(11):1114-23. Erratum in: N Engl J Med. 2005 Nov 24;353(21):2311. PMID: 16162882 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Results of a two-year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate.

    Kremer JM, Genant HK, Moreland LW, Russell AS, Emery P, Abud-Mendoza C, Szechiński J, Li T, Teng J, Becker JC, Westhovens R.

    Arthritis Rheum. 2008 Apr;58(4):953-63.PMID: 18383390 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Safety and efficacy of the selective costimulation modulator abatacept in patients with rheumatoid arthritis receiving background methotrexate: a 5-year extended phase IIB study.

    Westhovens R, Kremer JM, Moreland LW, Emery P, Russell AS, Li T, Aranda R, Becker JC, Qi K, Dougados M.

    J Rheumatol. 2009 Apr;36(4):736-42. Epub 2009 Feb 27.PMID: 19273451 [PubMed - indexed for MEDLINE]Related articles

    8.

    Selective costimulation modulation using abatacept in patients with active rheumatoid arthritis while receiving etanercept: a randomised clinical trial.

    Weinblatt M, Schiff M, Goldman A, Kremer J, Luggen M, Li T, Chen D, Becker JC.

    Ann Rheum Dis. 2007 Feb;66(2):228-34. Epub 2006 Aug 25.PMID: 16935912 [PubMed - indexed for MEDLINE]Related articles

    10.

    Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial.

    Ruperto N, Lovell DJ, Quartier P, Paz E, Rubio-Pérez N, Silva CA, Abud-Mendoza C, Burgos-Vargas R, Gerloni V, Melo-Gomes JA, Saad-Magalhães C, Sztajnbok F, Goldenstein-Schainberg C, Scheinberg M, Penades IC, Fischbach M, Orozco J, Hashkes PJ, Hom C, Jung L, Lepore L, Oliveira S, Wallace CA, Sigal LH, Block AJ, Covucci A, Martini A, Giannini EH; Paediatric Rheumatology INternational Trials Organization; Pediatric Rheumatology Collaborative Study Group.

    Lancet. 2008 Aug 2;372(9636):383-91. Epub 2008 Jul 14.PMID: 18632147 [PubMed - indexed for MEDLINE]Related articles

    11.

    Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.

    Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I.

    Arch Intern Med. 1999 Nov 22;159(21):2542-50.PMID: 10573044 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Role of abatacept in the management of rheumatoid arthritis.

    Nogid A, Pham DQ.

    Clin Ther. 2006 Nov;28(11):1764-78. Review.PMID: 17212998 [PubMed - indexed for MEDLINE]Related articles

    14.

    Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.

    Emery P, Kosinski M, Li T, Martin M, Williams GR, Becker JC, Blaisdell B, Ware JE Jr, Birbara C, Russell AS.

    J Rheumatol. 2006 Apr;33(4):681-9. Epub 2006 Mar 1.PMID: 16568505 [PubMed - indexed for MEDLINE]Related articles

    15.

    Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial.

    Klareskog L, van der Heijde D, de Jager JP, Gough A, Kalden J, Malaise M, Martín Mola E, Pavelka K, Sany J, Settas L, Wajdula J, Pedersen R, Fatenejad S, Sanda M; TEMPO (Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes) study investigators.

    Lancet. 2004 Feb 28;363(9410):675-81.PMID: 15001324 [PubMed - indexed for MEDLINE]Related articles

    17.

    Abatacept improves both the physical and mental health of patients with rheumatoid arthritis who have inadequate response to methotrexate treatment.

    Russell AS, Wallenstein GV, Li T, Martin MC, Maclean R, Blaisdell B, Gajria K, Cole JC, Becker JC, Emery P.

    Ann Rheum Dis. 2007 Feb;66(2):189-94. Epub 2006 Sep 19.PMID: 16984942 [PubMed - indexed for MEDLINE]Related articles

    18.

    Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomized, double-blind, placebo-controlled trial.

    Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM.

    Ann Intern Med. 2002 Nov 5;137(9):726-33.PMID: 12416946 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.

    Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V.

    Arthritis Rheum. 2001 Sep;44(9):1984-92.PMID: 11592358 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Abatacept.

    Hervey PS, Keam SJ.

    BioDrugs. 2006;20(1):53-61; discussion 62. Review.PMID: 16573350 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data